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Non-contrast computed tomography (NCCT) Alberta Stroke Program Early CT Score
(ASPECTS) and assessment of collateral flow with multiphase computed tomography angi-
ography (CTA) have been investigated as predictors of clinical outcome in patients with
acute ischemic stroke. This study assessed the value of multiphase CTA ASPECTS in pre-
dicting final infarction core and clinical outcome in patients undergoing endovascular treat-
ment of acute ischemic stroke.
Methods
We retrospectively studied consecutive patients who underwent multiphase CTA prior to
endovascular treatment of acute stroke due to anterior circulation large artery occlusion.
Multiphase CTA and final diffusion-weighted imaging (DWI) scans were evaluated by two
independent observers for NCCT ASPECTS, acute phase CTA (CTA-AP) ASPECTS,
delayed phase CTA (CTA-DP) ASPECTS, and final DWI ASPECTS. Modified Rankin Scale
score�2 at 3 months was considered a favorable outcome.
Results
A total of 74 patients were analyzed. We found that CTA-DP ASPECTS (r = 0.82; 95% CI,
0.73–0.91; p < 0.001) correlated with final DWI ASPECTS better than NCCT ASPECTS (r =
0.49; 95% CI, 0.39–0.59) and CTA-AP ASPECTS (r = 0.71; 95% CI, 0.64–0.78). Interob-
server agreement was higher for CTA-DP ASPECTS (k = 0.84). Good CTA-DP ASPECTS
was an independent predictor of favorable outcome (odds ratio, 8.71; 95% CI, 3.71–17.3; p
< 0.001).
Conclusion
CTA-DP ASPECTS is a reliable predictor of final infarction core and neurological outcome.
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Introduction
In the treatment of acute ischemic stroke due to anterior circulation large vessel occlusion,
endovascular treatment has become the standard therapy [1–3]. Effective methods to select
appropriate candidates who would benefit from endovascular treatment while avoiding futile
attempts at reperfusion are being introduced [4–6]. The Alberta Stroke Program Early CT
Score (ASPECTS) on non-contrast CT (NCCT) is widely used for the assessment of early
ischemic change [7, 8]. ASPECTS is a semiquantitative scale established to assess the extent of
early ischemic changes in patients with acute ischemic stroke of the middle cerebral artery [7].
The territory of the middle cerebral artery is divided into 10 regions, ASPECTS subtracts the
regions of early ischemic sign, such as hypoattenuation from the initial score of 10 [7, 8]. How-
ever, this has been debated as it is difficult to accurately determine early ischemic change on
NCCT and interrater reliability is modest [9]. Recent randomized controlled trials have used
the NCCT ASPECTS only as an exclusion criterion [1, 10, 11]. CTA quickly identifies large
vessel occlusion and shows early ischemic change better than NCCT [12–14]. In addition, a
few studies have shown that CTA ASPECTS can predict final infarct size and clinical outcome
better than NCCT ASPECTS [15, 16].
The status of collateral flow is strongly and independently associated with clinical outcome
in acute ischemic stroke [17–19]. Multiphase CTA is comprised of non-contrast (NCCT), arte-
rial (CTA-AP), and delayed (CTA-DP) phases and is useful to evaluate collateral status and
select patients for endovascular treatment [1, 18]. We hypothesized that multiphase CTA
ASPECTS reflects collateral status and thus final infarction volume and also clinical outcome.
Therefore, this study aimed to assess the value of each phase in predicting final infarction core
and clinical outcome in acute ischemic stroke patients undergoing endovascular treatment.
Methods
We reviewed the records of consecutive patients with acute ischemic stroke due to anterior
circulation large artery occlusion who underwent endovascular treatment between June
2014 and March 2016. The indication for endovascular treatment was an initial National
Institute of Health Stroke Scale (NIHSS) score �4 within 6 h of symptom onset and confir-
mation of large artery occlusion on multiphase CTA. Anterior circulation large arteries
were defined as the intracranial internal carotid artery (ICA), M1 segment of the middle
cerebral artery (MCA), and proximal M2 segment of the MCA. Intravenous tissue plasmin-
ogen activator (tPA) was administered (0.9 mg/kg) if indicated. Endovascular thrombect-
omy was subsequently performed without waiting for the tPA effect. All endovascular
treatment was performed under local anesthesia; conscious sedation was administered as
necessary. The method of endovascular treatment (stent-retriever thrombectomy, aspira-
tion thrombectomy, or both combined) depended on the treatment situation and prefer-
ence of the primary operator.
Magnetic resonance imaging (MRI), such as diffusion-weighted imaging (DWI) sequences
and time-of-flight angiography, was performed within 36 h in almost all patients who under-
went endovascular treatment. Demographic characteristics and NIHSS score were assessed in
all patients. The NIHSS score was reappraised within 24 h after treatment and at discharge.
Functional outcomes were assessed using the modified Rankin Scale (mRS) at 3 months.
This retrospective study was approved by Ilsan Paik hospital Institutional Review Board.
The Clinical Research Ethics Committee waived the need for written informed consent from
the participants because the data released from the hospital database were analyzed
anonymously.
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Image acquisition
All patients underwent standard NCCT with 5 mm section thickness followed by multiphase
CTA with a 64-detector row scanner (Aquilion 64; Toshiba Medical System, Tokyo, Japan).
Multiphase CTA was performed in three phases after contrast injection. The first phase (arte-
rial) was obtained from the aortic arch to the skull vertex during the peak arterial phase and
was triggered by bolus monitoring. Contrast media (80–100 mL) was injected at a rate of 5
mL/s followed by a 50 mL normal saline chase at a rate of 6 mL/s. Images were acquired with a
0.625 mm section thickness and reconstructed with 3 mm thickness at 1 mm intervals. The
first phase was obtained in less than 7 s, and the second and third phases were obtained after
respective delays of 4 s each that allowed for table repositioning to the skull base [18]. The
third phase CTA was used to determine CTA-DP ASPECTS. MRI (Avanto 1.5T; Siemens,
Erlangen, Germany), was performed within 36 h after endovascular treatment; DWI sequences
were used to determine the final ASPECTS.
Outcome measurement
Two board-certified neuroradiologists (J.W.K and B.H.L) independently assessed pretreat-
ment multiphase CTA and final DWI for determination of ASPECTS and assessment of recan-
alization success on cerebral angiography during endovascular treatment. Disagreement
between the two was resolved by consensus. Good ASPECTS was defined as a score from 8 to
10, as in a previously published study [20]. Recanalization success was defined as modified
Thrombolysis In Cerebral Ischemia (mTICI) grade 2b or 3 on the final angiogram. Total pro-
cedure time was defined as the time interval from femoral artery puncture to acquisition of
final angiography. Symptomatic intracranial hemorrhage (sICH) was defined as the presence
of a large parenchymal hematoma and NIHSS score increase�4 compared to admission.
Good outcome was defined as a mRS score�2 at 3 months.
Statistical analysis
Statistical analyses were performed using SPSS software version 20.0 (IBM Corp., Armonk,
NY, USA). All categorical variables are presented as numbers with frequency (%); continuous
variables are presented as means ± standard deviation or medians with interquartile range.
Correlations between pretreatment NCCT ASPECTS, multiphase CTA ASPECTS (CTA-AP
and CTA-DP) and final DWI ASPECTS scores were determined using the Spearman correla-
tion coefficient with confidence limits calculated using the Fisher z transformation.
Interobserver agreement for pretreatment CTA and final DWI ASPECTS were estimated
using Cohen’s kappa coefficient. The results were interpreted according to the standards for
strength of agreement proposed by Landis and Koch as follows: poor agreement,�0; slight
agreement, 0.1–0.20; fair agreement, 0.21–040; moderate agreement, 0.41–0.60; substantial
agreement, 0.61–0.80; and almost perfect agreement, 0.81–1.0 [21]. Univariate associations
with good clinical outcome were determined by the Fisher exact test, t-test, or Wilcoxon rank-
sum test as appropriate. A multivariate binary logistic regression model was constructed to
determine independent predictors of good clinical outcome; all variables that showed potential
association in the univariate analyses (p< 0.20) were included. P < 0.05 was considered
significant.
Results
A total of 74 patients who underwent pretreatment multiphase CTA, endovascular treatment
of anterior circulation large artery occlusion, and follow-up MRI were included for analysis.
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Mean patient age was 67.3 ± 14.2 years. Thirty-seven patients were male. Before treatment, the
median NCCT ASPECTS was 8 (IQR, 6–10), median CTA-AP ASPECTS was 5 (IQR, 1–8),
and median CTA-DP ASPECTS was 6 (IQR, 3–8). Median initial NIHSS score was 15 (IQR,
6–23). Successful recanalization (mTICI 2b–3) was achieved in 65 patients (88%) and mean
time from onset to recanalization was 301 ± 172 min. The final median DWI ASPECTS was 6
(IQR, 2–9). Patient clinical characteristics are shown in Table 1.
The correlation between CTA-DP ASPECTS (r = 0.82; 95% confidence interval (CI), 0.73–
0.91; p< 0.001) and final DWI ASPECTS was greater than that of NCCT ASPECTS (r = 0.49;
95% CI, 0.39–0.59) or CTA-AP ASPECTS (r = 0.71; 95% CI, 0.64–0.78) (Fig 1). Furthermore,
the cases of disagreement between the two observers in NCCT ASPECTS, CTA-AP ASPECTS,
and CTA-DP ASPECTS were 21, 9, and 7 cases, respectively. The interobserver agreement was
classified as almost perfect for CTA-DP ASPECTS (k = 0.84) and CTA-AP ASPECTS
(k = 0.81). Interobserver agreement for NCCT ASPECTS was classified as moderate (k = 0.58).
Factors predicting favorable outcome (mRS 0–2 at 3 months) in univariate analysis were
younger age, nonhypertension, nonsmoking, low initial NIHSS score, short time from stroke
onset to femoral puncture, more successful recanalization, low NIHSS score at 24 h, and good
NCCT, CTA-AP, and CTA-DP ASPECTS. In multivariate analysis, good CTA-DP and
CTA-AP ASPECTS (odds ratio, 4.21; 95% CI, 2.33–9.01; p = 0.021), age (odds ratio, 0.98; 95%
CI, 0.93–0.99; p< 0.001), initial NIHSS score (odds ratio, 0.95; 95% CI, 0.89–0.99; p< 0.001),
NIHSS score at 24 h (odds ratio, 0.91; 95% CI, 0.86–0.97; p = 0.015), and successful recanaliza-
tion (odds ratio, 3.52; 95% CI, 1.11–7.03; p = 0.027) remained independent predictors of favor-
able clinical outcome. Good CTA-DP ASPECTS (odds ratio, 8.71; 95% CI, 3.71–17.3;
p< 0.001) was the best predictor of favorable clinical outcome (Table 2).
Discussion
Our results demonstrate that CTA-DP ASPECTS is both a reliable tool to predict final infarct
score and an independent predictor of clinical outcome. NCCT is commonly used to detect
Table 1. Patient demographics and characteristics.
Variable n = 74
Mean age, years (SD) 67.3 (14.2)
Male, n (%) 37 (50.0)
Hypertension, n (%) 53 (71.6)
Diabetes mellitus, n (%) 19 (25.7)
Atrial fibrillation, n (%) 38 (51.4)
Smoking, n (%) 18 (24.3)
Use of intravenous tPA, n (%) 34 (45.9)
Median initial NIHSS score (IQR) 15 (6–23)
Mean time from onset to recanalization, min (SD) 301 (172)
Recanalization success (mTICI 2b–3), n (%) 65 (88%)
Pretreatment non-contrast CT ASPECTS, median (IQR) 8 (6–10)
Pretreatment CTA-AP ASPECTS, median (IQR) 5 (1–8)
Pretreatment CTA-DP ASPECTS, median (IQR) 6 (3–8)
Follow-up DWI ASPECTS, median (IQR) 6 (2–9)
tPA, tissue plasminogen activator; NIHSS, National Institutes of Health Stroke Scale; IQR, interquartile range;
mTICI, modified Thrombolysis In Cerebral Ischemia; ASPECTS, Alberta Stroke Program Early Computed
Tomography Score; AP, acute phase; DP, delayed phase; DWI, diffusion-weighted imaging
https://doi.org/10.1371/journal.pone.0239510.t001
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early ischemic parenchymal change and exclude acute hemorrhage in the management and
evaluation of acute ischemic stroke patients [7, 8]. Although the NCCT ASPECTS is often
used to quantitatively evaluate ischemic lesions, NCCT has difficulty detecting early ischemic
change and tends to underestimate infarct score [8, 9, 22]. However, NCCT is easily accessible
and is primarily used to exclude inappropriate acute stroke patients from undergoing futile
reperfusion therapy in today’s era of endovascular thrombectomy [1, 10–12]. On the other
hand, CTA is being used to select patients for endovascular treatment, as it can detect intracra-
nial large vessel occlusion [1–3, 11]. In addition, CTA source image ASPECTS has been shown
to be more sensitive than NCCT ASPECTS in the early detection of irreversible ischemic
Fig 1. Correlation of ASPECTS on NCCT (A), CTA-AP (B), and CTA-DP (C) with final DWI ASPECTS.
https://doi.org/10.1371/journal.pone.0239510.g001
Table 2. Univariable and multivariable analyses for favorable outcome.
Univariable analysis Multivariable analysis
mRS 0–2 (n = 39) mRS 3–6 (n = 35) p value Odds ratio (95% CI) p value
Age, years 64.8 (11.3) 71.8 (10.7) <0.001 0.98 (0.93–0.99) <0.001
Male 51% 49% 0.849 - -
Hypertension 64% 80% 0.004 0.99 (0.71–1.53) 0.405
Diabetes mellitus 26% 26% 0.947 - -
Atrial fibrillation 56% 46% 0.132 0.87 (0.81–1.24) 0.955
Smoking 18% 31% 0.013 1.10 (0.69–2.04) 0.580
Use of intravenous tPA 49% 43% 0.233 - -
Initial NIHSS score 13 (6–20) 17 (10–23) <0.001 0.95 (0.89–0.99) <0.001
Time from onset to recanalization, min 290 (±152) 315 (±161) 0.028 0.99 (0.91–1.05) 0.336
Recanalization success 92% 83% 0.004 3.52 (1.11–7.03) 0.027
sICH 10% 14% 0.56 - -
NIHSS at 24 h 5 (0–10) 13 (5–23) <0.001 0.91 (0.86–0.97) 0.015
Good NCCT ASPECTS 75% 63% 0.010 1.31 (0.68–2.27) 0.375
Good CTA-AP ASPECTS 37% 28% <0.001 4.21 (2.33–9.01) 0.021
Good CTA-DP ASPECTS 59% 25% <0.001 8.71 (3.71–17.3) <0.001
mRS, modified Rankin Scale; CI, confidence interval; tPA, tissue plasminogen activator; NIHSS, National Institutes of Health Stroke Scale; sICH, symptomatic
intracranial hemorrhage; ASPECTS, Alberta Stroke Program Early Computed Tomography Score; AP, acute phase; DP, delayed phase
https://doi.org/10.1371/journal.pone.0239510.t002
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damage and more accurate in the prediction of final infarct size [15, 16]. Sallustio et al. demon-
strated that CTA source image ASPECTS correlated better with follow-up ASPECTS than
NCCT ASPECTS (r = 0.76 vs r = 0.51) in patients undergoing endovascular thrombectomy
[15]. Kawiorski et al. showed that CTA source image ASPECTS can be a good tool to select
appropriate patients for endovascular treatment; a score�5 predicted futile recanalization
[16]. However, in those studies, it was difficult to correctly estimate overall cerebral perfusion
status because it was evaluated only by early arterial phase CTA. Multiphase CTA is a more
accurate evaluator of overall cerebral perfusion and collateral status [18, 23].
Various factors, including collateral status, are involved in maximizing endovascular treat-
ment effectiveness and preventing futile reperfusion [24–27]. According to several randomized
controlled trials, shorter time from stroke onset to reperfusion is associated with greater clini-
cal benefit of endovascular treatment [1–6]. However, approximately 32% of patients have an
unfavorable outcome even after a rapid and effective recanalization with endovascular treat-
ment [6]. Since infarct expansion is affected by collateral status, collateral status is an impor-
tant predictor of clinical outcome regardless of successful recanalization in many studies [18,
19]. Previous studies have shown that collateral status on multiphase CTA is independently
associated with clinical outcome [17–19]. The delayed phase is more likely to reflect maximum
collateral flow, including very delayed pial collateral flow, than the arterial phase, so CTA-DP
appears to reflect final perfusion status after large vessel occlusion. Our results support this
and show that CTA-DP ASPECTS highly correlates with follow-up DWI ASPECTS (Fig 2).
Fig 2. A patient in their 60s’ was admitted with acute left hemiparesis and dysarthria 45 min after symptom onset.
(A) Non-contrast computed tomography showed subtle hypodensity of the right insular cortex and lentiform nucleus.
(B) Arterial phase computed tomography angiography (CTA) demonstrated hypodensity involving the right insular
cortex, lentiform nucleus, internal capsule, and right parietotemporal lobe. (C) Delayed phase CTA demonstrated
subtle hypodensity of the right lentiform nucleus. (D) A right carotid angiogram showed an occlusion of the right
middle cerebral artery. (E) The angiogram after endovascular thrombectomy showed complete recanalization of the
middle cerebral artery. (F) Follow-up diffusion-weighted imaging demonstrated a small area of acute infarction in the
right lentiform nucleus.
https://doi.org/10.1371/journal.pone.0239510.g002
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According to the recent DWI or CTP Assessment with Clinical Mismatch in the Triage of
Wake-Up and Late Presenting Stroke Undergoing Neurointervention with Trevo (DAWN)
and Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke (DEFUSE 3) tri-
als, the time window for endovascular treatment of acute stroke has been extended to 24 h [28,
29]. Patients in these studies were selected based on perfusion imaging scans using RAPID
software (iSchemaView, Inc., Redwood City, CA, USA) to determine that the infarction core
volume was appropriate before endovascular treatment. However, in real practice, it may be
difficult for all institutions to use RAPID software. Our results suggest that CTA-DP ASPECTS
is better for predicting the final infarction core than NCCT or CTA-AP ASPECTS, which may
assist in patient selection for endovascular treatment.
This study has several limitations; these include its retrospective design, relatively small
sample size, and lack of mortality. In addition, it only included patients with follow-up DWI;
thus, patients who experienced serious neurologic deterioration that precluded follow-up MRI
were excluded and selection bias may have been introduced. However, this study aimed to
determine the correlation of pretreatment multiphase CTA ASPECTS with follow-up DWI,
the most accurate measure of final infarction core volume. Lastly, CTA ASPECTS criteria for
maximizing the therapeutic effect of endovascular therapy were not examined. Future larger
multicenter studies are needed to validate the use of multiphase CTA ASPECTS in clinical
decision-making.
Conclusion
Pretreatment CTA-DP ASPECTS predicts final infarction core volume and favorable clinical
outcome better than NCCT and CTA-AP ASPECTS in patients undergoing endovascular
treatment of acute ischemic stroke due to anterior circulation large vessel occlusion within 6 h
of symptom onset.
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